Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kelly

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Psychiatry|May 9, 2009
The safety, acceptability, and effectiveness of acupuncture as an adjunctive treatment for acute symptoms in bipolar disorderEllen B Dennehy, Rosa Schnyer, Ira H Bernstein, et al.
Diabetes|October 8, 2009
Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemiaWeiguo Li, Roshini Prakash, Aisha I Kelly-Cobbs, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 22, 2013
Targets of vascular protection in acute ischemic stroke differ in type 2 diabetesAisha I Kelly-Cobbs, Roshini Prakash, Weiguo Li, et al.
Journal of the American Academy of Dermatology|May 1, 2026
Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg)Michael E Jacobson, Justin W Ng, Laura Morales Leon, et al.
Medrxiv : the Preprint Server for Health Sciences|January 29, 2026
Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg)Michael E Jacobson, Justin W Ng, Laura Morales Leon, et al.
Journal of Affective Disorders|March 25, 2008
A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depressionTrisha Suppes, Lauren B Marangell, Ira H Bernstein, et al.
International Clinical Psychopharmacology|October 6, 2007
Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment NetworkTrisha Suppes, Dorothy I Kelly, Paul E Keck, et al.
JAMA Neurology|August 12, 2014
Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplementJuan M Pascual, Peiying Liu, Deng Mao, et al.
Archives of Dermatological Research|September 27, 2023
Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiativeOlivia M Haddadin, Michael E Jacobson, Diana M Chen, et al.
The British Journal of Dermatology|March 5, 2026
Minimum Data Set for Treatment Effectiveness in Pyoderma Gangrenosum for an International Registry: An International Multidisciplinary eDelphi ConsensusOlivia M Haddadin, Michael E Jacobson, Sarah L Becker, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Psychiatry|May 9, 2009
The safety, acceptability, and effectiveness of acupuncture as an adjunctive treatment for acute symptoms in bipolar disorderEllen B Dennehy, Rosa Schnyer, Ira H Bernstein, et al.
Diabetes|October 8, 2009
Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemiaWeiguo Li, Roshini Prakash, Aisha I Kelly-Cobbs, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 22, 2013
Targets of vascular protection in acute ischemic stroke differ in type 2 diabetesAisha I Kelly-Cobbs, Roshini Prakash, Weiguo Li, et al.
Journal of the American Academy of Dermatology|May 1, 2026
Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg)Michael E Jacobson, Justin W Ng, Laura Morales Leon, et al.
Medrxiv : the Preprint Server for Health Sciences|January 29, 2026
Initial development and pragmatic clinical validation of a static disease severity instrument for pyoderma gangrenosum: Investigator Global Assessment for PG (IGAPg)Michael E Jacobson, Justin W Ng, Laura Morales Leon, et al.
Journal of Affective Disorders|March 25, 2008
A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depressionTrisha Suppes, Lauren B Marangell, Ira H Bernstein, et al.
International Clinical Psychopharmacology|October 6, 2007
Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment NetworkTrisha Suppes, Dorothy I Kelly, Paul E Keck, et al.
JAMA Neurology|August 12, 2014
Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplementJuan M Pascual, Peiying Liu, Deng Mao, et al.
Archives of Dermatological Research|September 27, 2023
Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiativeOlivia M Haddadin, Michael E Jacobson, Diana M Chen, et al.
The British Journal of Dermatology|March 5, 2026
Minimum Data Set for Treatment Effectiveness in Pyoderma Gangrenosum for an International Registry: An International Multidisciplinary eDelphi ConsensusOlivia M Haddadin, Michael E Jacobson, Sarah L Becker, et al.
Pageof 11